Hamilton Lane Advisors’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-2,468
| Closed | -$400K | – | 84 |
|
|
2021
Q2 | $400K | Buy |
+2,468
| New | +$400K | 0.13% | 64 |
|
|
2020
Q4 | – | Sell |
-10,037
| Closed | -$839K | – | 51 |
|
|
2020
Q3 | $839K | Buy |
+10,037
| New | +$839K | 0.41% | 31 |
|
|
2017
Q4 | – | Sell |
-23,775
| Closed | -$425K | – | 57 |
|
|
2017
Q3 | $425K | Buy |
+23,775
| New | +$425K | 0.29% | 41 |
|